Microba Life Sciences Ltd has released a press release.
Therapeutic Program Advancement
Filed with ASX ·
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call6ix hasn’t read this filing yet.
Microba Life Sciences Limited on 6ix
In the deck
Earlier from Microba Life Sciences
- Investor Presentation - FY22 Update Annual Results
- Q4 FY22 Quarterly Activities Report & Appendix 4C
- G42 Healthcare Partnership Commences Operation
- Microba & Ginkgo Commence Therapeutics Program
- Partnership signed with nib-backed Midnight Health
Later from Microba Life Sciences
- Microba, SYNLAB Extend & Expand Distribution
- Q1 FY23 Quarterly Activities Report & Appendix 4C
- Microba receives $2.62m R&D Tax Incentive refund
- Sonic Acquires 19.9% Microba Stake and Enters Partnership
- Sonic Investment & Partnership Investor Presentation
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences